229 related articles for article (PubMed ID: 12475440)
21. Leukocyte-specific phosphoprotein-1 and PU.1: two useful markers for distinguishing T-cell-rich B-cell lymphoma from lymphocyte-predominant Hodgkin's disease.
Marafioti T; Mancini C; Ascani S; Sabattini E; Zinzani PL; Pozzobon M; Pulford K; Falini B; Jaffe ES; Müller-Hermelink HK; Mason DY; Pileri SA
Haematologica; 2004 Aug; 89(8):957-64. PubMed ID: 15339679
[TBL] [Abstract][Full Text] [Related]
22. Nodular lymphocyte-predominant hodgkin lymphoma with atypical T cells: a morphologic variant mimicking peripheral T-cell lymphoma.
Sohani AR; Jaffe ES; Harris NL; Ferry JA; Pittaluga S; Hasserjian RP
Am J Surg Pathol; 2011 Nov; 35(11):1666-78. PubMed ID: 21997687
[TBL] [Abstract][Full Text] [Related]
23. T-cell-rich B large-cell lymphoma simulating lymphocyte-rich Hodgkin's disease.
McBride JA; Rodriguez J; Luthra R; Ordóñez NG; Cabanillas F; Pugh WC
Am J Surg Pathol; 1996 Feb; 20(2):193-201. PubMed ID: 8554109
[TBL] [Abstract][Full Text] [Related]
24. Differential diagnosis of L26-positive, CD15-negative Hodgkin's disease and large B-cell lymphoma with a high content of reactive T-cells: a morphologic and immunohistochemical study.
Nguyen DT; Diamond LW; Hansmann ML; Fischer R
Hematopathol Mol Hematol; 1996; 10(3):135-50. PubMed ID: 8878732
[TBL] [Abstract][Full Text] [Related]
25. Histiocyte-rich B-cell lymphoma. A distinct clinicopathologic entity possibly related to lymphocyte predominant Hodgkin's disease, paragranuloma subtype.
Delabie J; Vandenberghe E; Kennes C; Verhoef G; Foschini MP; Stul M; Cassiman JJ; De Wolf-Peeters C
Am J Surg Pathol; 1992 Jan; 16(1):37-48. PubMed ID: 1728195
[TBL] [Abstract][Full Text] [Related]
26. TARC, a CC chemokine, is frequently expressed in classic Hodgkin's lymphoma but not in NLP Hodgkin's lymphoma, T-cell-rich B-cell lymphoma, and most cases of anaplastic large cell lymphoma.
Peh SC; Kim LH; Poppema S
Am J Surg Pathol; 2001 Jul; 25(7):925-9. PubMed ID: 11420464
[TBL] [Abstract][Full Text] [Related]
27. PD-1, a follicular T-cell marker useful for recognizing nodular lymphocyte-predominant Hodgkin lymphoma.
Nam-Cha SH; Roncador G; Sanchez-Verde L; Montes-Moreno S; Acevedo A; Domínguez-Franjo P; Piris MA
Am J Surg Pathol; 2008 Aug; 32(8):1252-7. PubMed ID: 18594468
[TBL] [Abstract][Full Text] [Related]
28. High expression of the CC chemokine TARC in Reed-Sternberg cells. A possible explanation for the characteristic T-cell infiltratein Hodgkin's lymphoma.
van den Berg A; Visser L; Poppema S
Am J Pathol; 1999 Jun; 154(6):1685-91. PubMed ID: 10362793
[TBL] [Abstract][Full Text] [Related]
29. CD20 positivity in classical Hodgkin's lymphoma: Diagnostic challenge or targeting opportunity.
Barakzai MA; Pervez S
Indian J Pathol Microbiol; 2009; 52(1):6-9. PubMed ID: 19136769
[TBL] [Abstract][Full Text] [Related]
30. T-cell-rich B-cell lymphoma and lymphocyte-predominant Hodgkin's disease: two closely related entities?
Schmidt U; Metz KA; Leder LD
Br J Haematol; 1995 Jun; 90(2):398-403. PubMed ID: 7794762
[TBL] [Abstract][Full Text] [Related]
31. Diagnostic Utility of Flow Cytometry Analysis of Reactive T Cells in Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
David JA; Huang JZ
Am J Clin Pathol; 2016 Jan; 145(1):107-15. PubMed ID: 26712878
[TBL] [Abstract][Full Text] [Related]
32. Lymphocyte-Rich Classical Hodgkin Lymphoma. A Case with Difficulty in Distinguishing from Nodular Lymphocyte-Predominant Hodgkin Lymphoma.
Sakai J; Tanae K; Takahashi N; Nagata K; Yoshino T; Tamaru J; Niitsu N
J Clin Exp Hematop; 2015; 55(1):23-8. PubMed ID: 26106003
[TBL] [Abstract][Full Text] [Related]
33. Lymphocyte-rich classical Hodgkin's lymphoma: distinctive tumor and microenvironment markers.
Nam-Cha SH; Montes-Moreno S; Salcedo MT; Sanjuan J; Garcia JF; Piris MA
Mod Pathol; 2009 Aug; 22(8):1006-15. PubMed ID: 19465900
[TBL] [Abstract][Full Text] [Related]
34. Characterization of variant patterns of nodular lymphocyte predominant hodgkin lymphoma with immunohistologic and clinical correlation.
Fan Z; Natkunam Y; Bair E; Tibshirani R; Warnke RA
Am J Surg Pathol; 2003 Oct; 27(10):1346-56. PubMed ID: 14508396
[TBL] [Abstract][Full Text] [Related]
35. Bone marrow involvement in T-cell-rich B-cell lymphoma.
Skinnider BF; Connors JM; Gascoyne RD
Am J Clin Pathol; 1997 Nov; 108(5):570-8. PubMed ID: 9353097
[TBL] [Abstract][Full Text] [Related]
36. Typing the histogenetic origin of the tumor cells of lymphocyte-rich classical Hodgkin's lymphoma in relation to tumor cells of classical and lymphocyte-predominance Hodgkin's lymphoma.
Bräuninger A; Wacker HH; Rajewsky K; Küppers R; Hansmann ML
Cancer Res; 2003 Apr; 63(7):1644-51. PubMed ID: 12670918
[TBL] [Abstract][Full Text] [Related]
37. Cellular origin of nodular lymphocyte-predominant Hodgkin's lymphoma: immunophenotypic and molecular studies.
Chan WC
Semin Hematol; 1999 Jul; 36(3):242-52. PubMed ID: 10462324
[TBL] [Abstract][Full Text] [Related]
38. IgD positive L&H cells identify a unique subset of nodular lymphocyte predominant Hodgkin lymphoma.
Prakash S; Fountaine T; Raffeld M; Jaffe ES; Pittaluga S
Am J Surg Pathol; 2006 May; 30(5):585-92. PubMed ID: 16699312
[TBL] [Abstract][Full Text] [Related]
39. [The clinical and pathological characteristics of 14 patients' nodular lymphocyte predominant Hodgkin's lymphoma].
Liu S; Ma J; Yue Y; Li Q; Yang H; Zhao H; Zhao W; Yu Y; Wang X; Zhao Z; Wang Y; Zhang Y
Zhonghua Xue Ye Xue Za Zhi; 2015 Jan; 36(1):20-3. PubMed ID: 25641140
[TBL] [Abstract][Full Text] [Related]
40. CD30-positive T-cell lymphomas co-expressing CD15: an immunohistochemical analysis.
Gorczyca W; Tsang P; Liu Z; Wu CD; Dong HY; Goldstein M; Cohen P; Gangi M; Weisberger J
Int J Oncol; 2003 Feb; 22(2):319-24. PubMed ID: 12527929
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]